"I'm sorry, but I scream FOUL!!!
....This situation is so contrived and blatant, it screams foul. This could only happen in the extreme volatility of the biotech arena where traders want their profits yesterday. Especially when a stock becomes overweighed in speculators verses investors. And that is exactly what happened last week. The get rich in 1 week crowed ran for the exits before management even uttered 1 sentence in the conference call. Everyone without thinking just sold everything at the market, along with the help in my opinion of some unscrupulous funds and the market makers (who are suppose to keep a neat orderly market, but seldom do when they sense panic and an opportunity to profit on that panic). The market seeing what amounted to people jumping from their windows was very happy to give them all 50 cents on the dollar for their hasty actions while they collected stock at a severe discount.
People..........Dr. Allan may not have done a good job of explaining the settlement to complete impatient morons, but it is not to hard for a person of minor reasonable intelligence to understand what a significant milestone this settlement is. I see posted over and over again that Insmed just gave up 50% of their going forward profits which to me is another way of saying.............. my reading and comprehension skills are that of a second grader. This company not only is now free to develop IPLEX without any roadblocks (lawsuits, litigation, patent infringement, etc.) for the extremely lucrative markets (we all invested for in the first place) that could lead to a $50 or higher stock price................But they also have one of the worlds largest, greediest, most powerful pharmaceutical corporations interested in assuming 50% of all incurred costs, past, present, and future, in exchange for a 50% profit-sharing structure. This deal is so good it boggles the mind how anyone can interpret this as a negative.
If this were the software sector, and a small struggling cash strapped company with a very novel piece of software were approached by Microsoft with the same deal, that small struggling cash strapped company's stock would go up several hundred percent. But we're not in the software sector, we're in the biotech sector and happen to have more traders than investors in this stock so we fell 50%. Just unbelievable. We now have a ready made market with one of the largest bio sales forces on the planet (why would we need our own sales force?) who wants nothing more than for IPLEX to be a multi-billion dollar drug. All Insmed needs to do is what they have already done in the past........... Get FDA approval.......... We already know the drug is safe, so that is not an issue, so it is now down to efficacy which has been more than promising too date.
For crying out loud, if ever there was a stock that showed so much promise with so little investor respect, Insmed would certainly be it. And to all those on this board that are screaming Insmed is finished once IPLEX is taken off the short stature market I say..............What market?!!!!!!!!!!!............Go listen to TRCA's conference call if you want to learn about that market. I pity TRCA for trying to make it on that market. The market for IPLEX is the future and is in the billions!!!!..........not the few million best case scenario short stature would provide!!...........Especially with DNA as a partner. And for those of you who still believe that the short stature market is so important, this story isn't over yet. When parents, doctors, and patients, not to mention results, get to voice their opinions not only will it cast TRCA in a negative public light, it will help IPLEX become a common household name before it is even available. I think it already has! Everyone will know the name IPLEX while no one will be able to even say Incr.....what?"
BY pyracon YMB
AI
